<SEC-DOCUMENT>0001415889-25-004201.txt : 20250214
<SEC-HEADER>0001415889-25-004201.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214174002
ACCESSION NUMBER:		0001415889-25-004201
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CG Oncology, Inc.
		CENTRAL INDEX KEY:			0001991792
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				371611499
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94327
		FILM NUMBER:		25631347

	BUSINESS ADDRESS:	
		STREET 1:		400 SPECTRUM CENTER DRIVE
		STREET 2:		SUITE 2040
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		(949) 419-6203

	MAIL ADDRESS:	
		STREET 1:		400 SPECTRUM CENTER DRIVE
		STREET 2:		SUITE 2040
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Decheng Capital Global Life Sciences Fund IV, L.P.
		CENTRAL INDEX KEY:			0001834150
		ORGANIZATION NAME:           	
		IRS NUMBER:				981568621
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O MAPLES CORPORATE SERVICES LIMITED
		STREET 2:		UGLAND HOUSE, P.O. BOX 309
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		345-949-8066

	MAIL ADDRESS:	
		STREET 1:		C/O MAPLES CORPORATE SERVICES LIMITED
		STREET 2:		UGLAND HOUSE, P.O. BOX 309
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
		<previousAccessionNumber>0001104659-24-012374</previousAccessionNumber>
	    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001834150</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>





    </filerInfo>
  </headerData>

  <formData>
    <coverPageHeader>
		<amendmentNo>2</amendmentNo>
	      <securitiesClassTitle>Common stock, $0.0001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001991792</issuerCik>        <issuerName>CG ONCOLOGY, INC.</issuerName>        <issuerCusip>156944100</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>400 Spectrum Center Drive, Suite 2040</com:street1>
                    <com:city>Irvine</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92618</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>

	        <designateRulesPursuantThisScheduleFiled>
	   				        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
		      </designateRulesPursuantThisScheduleFiled>

    </coverPageHeader>

	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>Decheng Capital Global Life Sciences Fund IV, L.P.</reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>E9</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                          <sharedVotingPower>5315954.00</sharedVotingPower>
                          <soleDispositivePower>0.00</soleDispositivePower>
                         <sharedDispositivePower>5315954.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5315954.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>7.0</classPercent>





	        <typeOfReportingPerson>PN</typeOfReportingPerson>









    </coverPageHeaderReportingPersonDetails>
	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>Decheng Capital Management IV (Cayman), LLC</reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>E9</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                          <sharedVotingPower>5315954.00</sharedVotingPower>
                          <soleDispositivePower>0.00</soleDispositivePower>
                         <sharedDispositivePower>5315954.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5315954.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>7.0</classPercent>











	        <typeOfReportingPerson>OO</typeOfReportingPerson>



    </coverPageHeaderReportingPersonDetails>
	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>Decheng Capital Global Healthcare Fund (Master), LP </reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>E9</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                          <sharedVotingPower>1055715.00</sharedVotingPower>
                          <soleDispositivePower>0.00</soleDispositivePower>
                         <sharedDispositivePower>1055715.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1055715.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>1.4</classPercent>





	        <typeOfReportingPerson>PN</typeOfReportingPerson>









    </coverPageHeaderReportingPersonDetails>
	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>Decheng Capital Global Healthcare GP, LLC </reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>E9</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                          <sharedVotingPower>1055715.00</sharedVotingPower>
                          <soleDispositivePower>0.00</soleDispositivePower>
                         <sharedDispositivePower>1055715.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1055715.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>1.4</classPercent>











	        <typeOfReportingPerson>OO</typeOfReportingPerson>



    </coverPageHeaderReportingPersonDetails>
	    <coverPageHeaderReportingPersonDetails>




    <reportingPersonName>Xiangmin Cui</reportingPersonName>

	  		<memberGroup>b</memberGroup>


		 <citizenshipOrOrganization>X1</citizenshipOrOrganization>

      <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                          <sharedVotingPower>6371669.00</sharedVotingPower>
                          <soleDispositivePower>0.00</soleDispositivePower>
                         <sharedDispositivePower>6371669.00</sharedDispositivePower>
             </reportingPersonBeneficiallyOwnedNumberOfShares>

              <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>6371669.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>


     	    <classPercent>8.4</classPercent>










	        <typeOfReportingPerson>IN</typeOfReportingPerson>




    </coverPageHeaderReportingPersonDetails>

    <items>
      <item1>
        <issuerName>CG ONCOLOGY, INC.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>400 Spectrum Center Drive, Suite 2040, Irvine, CA, 92618.</issuerPrincipalExecutiveOfficeAddress>
      </item1>

      <item2>
        <filingPersonName>The names of the persons filing this report (collectively, the "Reporting Persons") are:

Decheng Capital Global Life Sciences Fund IV, L.P. ("Fund IV")
Decheng Capital Management IV (Cayman), LLC ("GP IV")
Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare")
Decheng Capital Global Healthcare GP, LLC ("Healthcare GP")
Xiangmin Cui ("Dr. Cui")

The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.</filingPersonName>        <principalBusinessOfficeOrResidenceAddress>3000 Sand Hill Road, Building 2, Suite 110
Menlo Park, CA 94025</principalBusinessOfficeOrResidenceAddress>        <citizenship>Fund IV			Cayman Islands
GP IV			Cayman Islands
Healthcare 		Cayman Islands
Healthcare GP	Cayman Islands
Dr. Cui		 	United States 	</citizenship>      </item2>

        <item3>
		        <notApplicableFlag>Y</notApplicableFlag>

      </item3>



    <item4>
    <amountBeneficiallyOwned>Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2024 and is incorporated by reference.

The Reporting Persons' ownership of the Issuer's securities consists of (i) 5,315,954 shares of common stock held directly by Fund IV and (ii) 1,055,715 shares of common stock held directly by Healthcare. GP IV is the general partner of Fund IV and shares voting and investment authority over the shares held by Fund IV. Healthcare GP is the general partner of Healthcare and shares voting and investment authority over the shares held by Healthcare.  Dr. Cui is the manager of GP IV and the indirect managing member and ultimate beneficial owner of Healthcare GP. Dr. Cui shares voting and investment authority over the shares held by each of Fund IV and Healthcare.</amountBeneficiallyOwned>    <classPercent>Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2024 and is incorporated by reference. The percentage set forth in each row 11 is based upon 76,037,858 shares of the Issuer's common stock outstanding as of December 16, 2024, as reported in the Issuer's prospectus dated December 12, 2024  filed with the Securities and Exchange Commission (the "SEC") on December 13, 2024.</classPercent>
      <numberOfSharesPersonHas>
        <solePowerOrDirectToVote>Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2024 and is incorporated by reference.</solePowerOrDirectToVote>
        <sharedPowerOrDirectToVote>Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2024 and is incorporated by reference.</sharedPowerOrDirectToVote>
        <solePowerOrDirectToDispose>Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2024 and is incorporated by reference.</solePowerOrDirectToDispose>
        <sharedPowerOrDirectToDispose>Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2024 and is incorporated by reference.</sharedPowerOrDirectToDispose>
      </numberOfSharesPersonHas>
    </item4>


        <item5>
	          <notApplicableFlag>Y</notApplicableFlag>


    </item5>


        <item6>
	  	  <notApplicableFlag>Y</notApplicableFlag>
		        </item6>


        <item7>
	  	  <notApplicableFlag>Y</notApplicableFlag>


    </item7>


          <item8>
                <notApplicableFlag>Y</notApplicableFlag>

              </item8>


            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
                      </item9>


      <item10>
                <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>

      </item10>
    </items>

		<exhibitInfo>Exhibit 99.1	Joint Filing Agreement</exhibitInfo>

	    <signatureInformation>
      <reportingPersonName>Decheng Capital Global Life Sciences Fund IV, L.P.</reportingPersonName>

      <signatureDetails>
        <signature>/s/ Xiangmin Cui </signature>
        <title>By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager</title>
        <date>02/14/2025</date>
      </signatureDetails>

    </signatureInformation>
	     <signatureInformation>
      <reportingPersonName>Decheng Capital Management IV (Cayman), LLC</reportingPersonName>

      <signatureDetails>
        <signature>/s/ Xiangmin Cui </signature>
        <title>By Xiangmin Cui, Manager</title>
        <date>02/14/2025</date>
      </signatureDetails>

    </signatureInformation>
	     <signatureInformation>
      <reportingPersonName>Decheng Capital Global Healthcare Fund (Master), LP </reportingPersonName>

      <signatureDetails>
        <signature>/s/ Xiangmin Cui </signature>
        <title>By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager</title>
        <date>02/14/2025</date>
      </signatureDetails>

    </signatureInformation>
	     <signatureInformation>
      <reportingPersonName>Decheng Capital Global Healthcare GP, LLC </reportingPersonName>

      <signatureDetails>
        <signature>/s/ Xiangmin Cui </signature>
        <title>By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager</title>
        <date>02/14/2025</date>
      </signatureDetails>

    </signatureInformation>
	     <signatureInformation>
      <reportingPersonName>Xiangmin Cui</reportingPersonName>

      <signatureDetails>
        <signature>/s/ Xiangmin Cui </signature>
        <title>Xiangmin Cui </title>
        <date>02/14/2025</date>
      </signatureDetails>

    </signatureInformation>



  </formData>


    </edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99-02142025_100259.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<!DOCTYPE html PUBLIC "-//IETF//DTD HTML//EN">
<html><head><title>ex-99-02142025_100259.htm</title></head><body style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<p style="margin:0px; padding-left:60px" align="center">EXHIBIT 99.1</p>
<p style="margin:0px" align="center"><br></p>
<p style="margin:0px; padding-left:60px" align="center">JOINT FILING AGREEMENT</p>
<p style="margin:0px" align="center"><br></p>
<p style="margin:0px">The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of CG Oncology, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.</p>
<p style="margin:0px"><br></p>
<p style="margin:0px">Dated: &nbsp;February 14, 2025</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>Decheng Capital Global Life Sciences Fund IV, L.P.</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px">Decheng Capital Management IV (Cayman), LLC</p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; clear:left; float:left">Its:</p>
<p style="margin:0px; text-indent:-2px">&nbsp;General Partner</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Xiangmin Cui</u></p>
<p style="margin:0px; clear:left">Name: &nbsp;Xiangmin Cui</p>
<p style="margin:0px">Title: &nbsp;Manager</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>Decheng Capital Management IV (Cayman), LLC</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Xiangmin Cui</u></p>
<p style="margin:0px; clear:left">Name: &nbsp;Xiangmin Cui</p>
<p style="margin:0px">Title: &nbsp;Manager</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>Decheng Capital Global Healthcare Fund (Master), LP </b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px">Decheng Capital Global Healthcare GP, LLC</p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; clear:left; float:left">Its:</p>
<p style="margin:0px; text-indent:-2px">&nbsp;General Partner</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px">Decheng Capital LLC</p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; clear:left; float:left">Its:</p>
<p style="margin:0px; text-indent:-2px">Manager</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Xiangmin Cui</u></p>
<p style="margin:0px; clear:left">Name: &nbsp;Xiangmin Cui</p>
<p style="margin:0px">Title: &nbsp;Manager</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>Decheng Capital Global Healthcare GP, LLC</b></p>
<p style="margin:0px"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px">Decheng Capital LLC</p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; clear:left; float:left">Its:</p>
<p style="margin:0px; text-indent:-2px">Manager</p>
<p style="margin:0px; clear:left"><br></p>
<p style="margin-top:0px; margin-bottom:-2px; width:30px; float:left">By:</p>
<p style="margin:0px; text-indent:-2px"><u>/s/ Xiangmin Cui</u></p>
<p style="margin:0px; clear:left">Name: &nbsp;Xiangmin Cui</p>
<p style="margin:0px">Title: &nbsp;Manager</p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><b>Xiangmin Cui</b></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><u>/s/ Xiangmin Cui</u></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
<p style="margin:0px"><br></p>
</body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
